Anti-PD-L1 immunotherapy responsive in microsatellite-stable mCRC comb with MEK inhibition

Go to article

Posted by on June 29, 2016 2:59 pm
Tags:
Categories: health

Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with a MEK inhibitor, according to phase I data.

Leave a Reply

Your email address will not be published. Required fields are marked *

< Buzz Post home